Seminars in Diagnostic Pathology
Volume 23, Issue 3 , Pages 149-160 , August 2006

Alcoholic liver disease

  • William W. Yip, MB, ChB

      Affiliations

    • Department of Pathology, Alice Ho Miu Ling Nethersole Hospital, Tai Po, New Territories, Hong Kong
    • ,
  • Alastair D. Burt, BSc, MD, FRCPath, FIBiol

      Affiliations

    • Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, England.
    • Corresponding Author InformationAddress reprint requests and correspondence: Alastair D. Burt, BSc, MD, FRCPath, FIBiol, Dean of Clinical Medicine’s Office, Peacock Hall, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, England.

References 

  1. Keller M. A historical overview of alcohol and alcoholism. Cancer Res. 1979;39:2822–2829
  2. Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004;24:217–232
  3. Bassendine MF, Day CP. The inheritance of alcoholic liver disease. Baillières Clin Gastroenterol. 1998;12:317–335
  4. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis. 2005;9:37–53
  5. Ishak KG, Zimmerman HJ, Ray MB. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res. 1991;15:45–66
  6. MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis. 1986;6:221–232
  7. Baptista A, Bianchi L, De Groote J, et al. Alcoholic liver disease: morphological manifestations. Lancet. 1981;1:707–711
  8. Diehl AM, Goodman Z, Ishak KG. Alcohol like liver disease in nonalcoholics (A clinical and histologic comparison with alcohol-induced liver injury). Gastroenterology. 1988;95:1056–1062
  9. Brunt EM. Non-alcoholic fatty liver disease. In:  Burt AD,  Portmann BC,  Ferrell LD editor. MacSween’s Pathology of the Liver. (ed 5). Edinburgh: Churchill Livingstone; 2006;p. 367–398
  10. Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol. 1998;15:246–258
  11. Williams R. Global challenges in liver disease. Hepatology. 2006;44:521–526
  12. Dam-Larsen S, Franzmann MB, Christofferson P, et al. Histological characteristics and prognosis in patients with fatty liver. Scand J Gastroenterol. 2005;40:460–467
  13. Lieber CS. Metabolism of alcohol. Clin Liver Dis. 2005;9:1–35
  14. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol. 2004;34:9–19
  15. Uchida T, Kao H, Quispe-Sjogren M, et al. Alcoholic foamy degeneration–a pattern of acute alcoholic injury of the liver. Gastroenterology. 1983;84:683–692
  16. Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis (Effects of drugs, ethanols, hormones and cytokines). J Hepatol. 1997;26(suppl):43–53
  17. Teli MR, Day CP, Burt AD, et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 1995;346:987–990
  18. Christoffersen P, Braendstrup O, Juhl E, et al. Lipogranulomas in human liver biopsies with fatty change (A morphological, biochemical and clinical investigation). Acta Pathol Microbiol Scand [A]. 1971;79:150–158
  19. Randall B. Sudden death and hepatic fatty metamorphosis: a North Carolina survey. JAMA. 1980;293:1723–1725
  20. Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig Dis. 2005;23:255–263
  21. Jensen K, Gluud C. The Mallory body: theories on development and pathological significance (part 2 of a literature survey). Hepatology. 1994;20:1330–1342
  22. Pei RJ, Danbara N, Tsujita-Kyutoki M, et al. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies. Med Electron Microsc. 2004;37:114–118
  23. Vyberg M, Leth P. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease. APMIS Suppl. 1991;99:46–52
  24. Zatloukal K, Stumptner C, Fuchsbichler A, et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol. 2002;160:255–263
  25. McClain CJ, Song Z, Barve SS, et al. Recent advances in alcoholic liver disease (IV. Dysregulated cytokine metabolism in alcoholic liver disease). Am J Physiol Gastrointest Liver Physiol. 2004;287:G497–G502
  26. Thiele GMFTL, Klaasen LW. Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis. 2004;24:273–287
  27. Farrell GC. Drugs and steatohepatitis. Semin Liver Dis. 2002;22:185–194
  28. Bruguera M, Bertran A, Bombi JA, et al. Giant mitochondria in hepatocytes: a diagnostic hint for alcoholic liver disease. Gastroenterology. 1977;73:1383–1387
  29. Feldstein AE, Gores GJ. Apoptosis in alcoholic and non-alcoholic steatohepatitis. Front Biosci. 2005;10:3093–3099
  30. Ribeiro PS, Cortez-Pinto H, Sola S, et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of non-alcoholic and alcoholic steaetohepatitis patients. Am J Gastroenterol. 2004;99:1708–1717
  31. Mundt B, Wirth T, Zender L, et al. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut. 2005;54:1590–1596
  32. Van Waes L, Lieber CS. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology. 1977;73:646–650
  33. Savolainen V, Perola M, Lalu K, et al. Early perivenular fibrogenesis: precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. J Hepatol. 1995;23:524–531
  34. Siegmund SV, Dooley S, Brenner DA. Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig Dis. 2005;23:264–274
  35. Edmondson HA, Peters RL, Reynolds TB, et al. Sclerosing hyaline necrosis of the liver in the chronic alcoholic (A recognizable clinical syndrome). Ann Intern Med. 1963;59:646–673
  36. Diehl AM. Recent events in alcoholic liver disease (V. Effects of ethanol on liver regeneration). Am J Physiol Gastrointest Liver Physiol. 2005;288:G1–G6
  37. Berresford PA, Sunter JP, Harrison V, et al. Histological demonstration and frequency of intrahepatocytic copper in patients suffering from alcoholic liver disease. Histopathology. 1980;4:637–643
  38. Pariente EA, Degott C, Martin JP, et al. Hepatocytic PAS-positive diastase-resistant inclusions in the absence of alpha-1-antitrypsin deficiency: high prevalence in alcoholic cirrhosis. Am J Clin Pathol. 1981;76:299–302
  39. Graziadei IW, Joseph JJ, Wiesner RH, et al. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology. 1998;28:1058–1063
  40. Lee FI. Cirrhosis and hepatoma in alcoholics. Gut. 1966;7:77–85
  41. Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis. 2005;9:151–169
  42. Marrero JA, Fontana RJ, Fu S, et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol. 2005;42:218–224
  43. Libbrecht LDV, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int. 2005;25:16–27
  44. Nakashima O, Kurogi M, Yamaguchi R, et al. Unique hypervascular nodules in alcoholic liver cirrhosis; identical to focal nodular hyperplasia-like lesions. J Hepatol. 2004;41:992–998
  45. Shaahib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005;128:620–626
  46. Popper H, Lieber CS. Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol. 1980;98:695–716
  47. Nakano M, Worner TM, Lieber CS. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA. 1985;254:627–630
  48. Burt AD, MacSween RNM. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol. 1986;39:63–67
  49. Goodman ZD, Ishak KG. Occlusive venous lesions in alcoholic liver disease (A study of 200 cases). Gastroenterology. 1982;83:786–796
  50. Wanless IR. Vascular disorders. In:  Burt AD,  Portmann BC,  Ferrell LD editor. MacSween’s Pathology of the Liver. (ed 5). Edinburgh: Churchill Livingstone; 2006;p. 613–648
  51. Colombat M, Charlotte F, Ratziu V, et al. Portal lymphocytic infiltrate in alcoholic liver disease. Hum Pathol. 2002;33:1170–1174
  52. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641–649
  53. Takase S, Takada N, Enomoto N, et al. Different types of chronic hepatitis in alcoholic patients: does chronic hepatitis induced by alcohol exist?. Hepatology. 1991;13:876–881
  54. Morgan MY, Sherlock S, Scheuer PJ. Portal fibrosis in the livers of alcoholic patients. Gut. 1978;19:1015–1021
  55. Michalak S, Rousselet MC, Bedossa P, et al. Respective roles of porto-septal and centrilobular fibrosis in alcoholic liver disease. J Pathol. 2003;201:55–62
  56. Afroudakis A, Kaplowitz N. Liver histopathology in chronic common bile duct stenosis due to chronic alcoholic pancreatitis. Hepatology. 1981;1:65–72
  57. Ray MB, Mendenhall CL, French SW, et al. The Veterans Administration Cooperative Study Group Bile duct changes in alcoholic liver disease. Liver. 1993;13:36–45
  58. Karakucuk I, Dilly SA, Maxwell JD. Portal tract macrophages are increased in alcoholic liver disease. Histopathology. 1989;14:245–253
  59. Roskams T, Desmet V. Ductular reaction and its diagnostic significance. Semin Diag Pathol. 1998;15:259–269
  60. Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol. 2003;163:1301–1311
  61. Jakobovits AW, Morgan MY, Sherlock S. Hepatic siderosis in alcoholics. Dig Dis Sci. 1979;24:305–310
  62. Kohgo Y, Ohtake T, Ikuta K, et al. Iron accumulation in alcoholic liver disease. Alcohol Clin Exp Res. 2005;29(suppl):189S–193S
  63. Tavill AS, Qadri AM. Alcohol and iron. Semin Liver Dis. 2004;24:317–325
  64. MacDonald RA. Wine as source of iron in haemochromatosis. Nature. 1963;199:922
  65. Pascoe A, Kerlin P, Jones D. Spur cell anemia explains the iron overload in advanced cirrhosis (C282Y negative). Hepatology. 2000;32:159
  66. Raynard B, Balian A, Fallik D, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology. 2002;35:635–638
  67. Eng SC, Taylor SL, Reyes V, et al. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis. Liver Int. 2005;25:513–517
  68. Cortes JM, Oliva H, Paradinas FJ, et al. The pathology of the liver in porphyria cutanea tarda. Histopathology. 1980;4:471–485
  69. Gerber MA, Thung SN. Hepatic oncocytes (Incidence, staining characteristics, and ultrastructural features). Am J Clin Pathol. 1981;75:498–503
  70. Levitsky J, Mailliard ME. Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis. 2004;24:233–247
  71. Watt KDS, McCashland TM. Transplantation in the alcoholic patient. Semin Liv Dis. 2004;24:249–255
  72. Fauerholdt L, Schlichting P, Christensen E, et al. Conversion of micronodular cirrhosis into macronodular cirrhosis. Hepatology. 1983;3:928–931
  73. Naveau S, Giraud V, Borotto E, et al. Excess weight risk factor for alcoholic liver disease. Hepatology. 1997;25:108–111
  74. Diehl AM. Obesity and alcoholic liver disease. Alcohol. 2004;34:81–87
  75. Powell EE, Ali A, Clouston AD, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology. 2005;129:1937–1943
  76. Hayashi PH, Harrison SA, Torgerson S, et al. Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. Am J Gastroenterol. 2004;99:76–81
  77. Gomes de Sa Ribeiro MF, da Costa Gayotto LC, de Alencar Fischer Chamone D, et al. Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C. Ann Hepatol. 2005;4:176–183
  78. Tamai T, Seki T, Shiro T, et al. Effects of alcohol consumption on histological changes in chronic hepatitis C: a clinicopathological study. Alcohol Clin Exp Res. 2000;24(suppl):106S–111S
  79. Tanaka T, Yabusako T, Yamashita T, et al. Contribution of hepatitis C virus to the progression of alcoholic liver disease. Alcohol Clin Exp Res. 2000;24(suppl):112S–116S
  80. Safdar K, Schiff ER. Alcohol and hepatitis C. Semin Liver Dis. 2004;24:305–315
  81. Fletcher LM, Powell LW. Hemochromatosis and alcoholic liver disease. Alcohol. 2003;30:131–136
  82. Morita Y, Ueno T, Sasaki N, et al. Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan. Alcohol Clin Exp Res. 2005;29:277S–281S
  83. Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353–358
  84. Forrest EH, Evans CD, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54:1174–1179
  85. Thabut D, Naveau S, Charlotte F, et al. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. J Hepatol. 2006;44:1175–1185
  86. Chedid A, Mendenhall CL, Gartside P, et al. VA Cooperative Study Group Prognostic factors in alcoholic liver disease. Am J Gastroenterol. 1991;86:210–216
  87. Talley NJ, Roth A, Woods J, et al. Diagnostic value of liver biopsy in alcoholic liver disease. J Clin Gastroenterol. 1988;10:647–650
  88. Nissenbaum M, Chedid A, Mendenhall C, et al. Prognostic significance of cholestatic alcoholic hepatitis. Dig Dis Sci. 1990;35:891–896
  89. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419
  90. Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol. 2004;40:860–867
  91. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology. 2005;41:1313–1321
  92. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–2474
  93. Verill CL, Markham H, Sheron N. Correlation of histological features on liver biopsy in patients with alcohol-induced cirrhosis. J Pathol. 2006;210(suppl):21A

PII: S0740-2570(06)00171-7

doi: 10.1053/j.semdp.2006.11.002

Seminars in Diagnostic Pathology
Volume 23, Issue 3 , Pages 149-160 , August 2006

Article Tools

* Image Usage & Resolution